Insight Capital Research & Management’s Integra LifeSciences IART Stock Holding History

Insight Capital Research & Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-61,236	Closed	-$2.53M	–	125
2016 Q3	$2.53M	Sell	61,236 -11,858	-16%	-$497K	1.13%	41
2016 Q2	$2.92M	Sell	73,094 -7,948	-10%	-$286K	1.02%	45
2016 Q1	$2.73M	Buy	+81,042	New	+$2.52M	0.85%	62

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Insight Capital Research & Management's IART Position: Q4 2016 in Review

Insight Capital Research & Management sold out of Integra LifeSciences (IART) in Q4 2016, closing a stake of 61,236 shares — an estimated $2.53M sold.

Insight Capital Research & Management first reported a position in IART in Q1 2016 and held it in 3 quarters. The position peaked at $2.92M in Q2 2016. 223 funds tracked by Wall St. Rank hold IART as of Q4 2016.

Insight Capital Research & Management reported no remaining Integra LifeSciences position as of Q4 2016 after selling out during the quarter.
Insight Capital Research & Management sold 61,236 Integra LifeSciences shares in Q4 2016, an estimated $2.53M.
Insight Capital Research & Management first reported a position in Integra LifeSciences in Q1 2016 and held it in 3 quarters.
Insight Capital Research & Management's Integra LifeSciences position peaked at $2.92M in Q2 2016.
223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.

Based on Insight Capital Research & Management's 13F filing for Q4 2016, filed 17 Feb 2017.